Risk-benefit analysis and clinical evaluation need to be on IMDRF's priority list, says EU
This article was originally published in Clinica
Executive Summary
The EU will be pushing for the International Medical Device Regulators Forum to make risk-benefit analysis and clinical evaluation key work priorities.